In line with Canteen’s strategic plan, our policy and advocacy work seeks to build an integrated and holistic healthcare system that identifies, understands and responds to the unique needs of adolescents, young adults and families impacted by cancer.
Advocacy
This submission focuses on treatment and support for young people and families impacted by a cancer diagnosis.
Advocacy
This submission highlights the areas we believe are effective as well as opportunities for improvement in Adult & Young Adult (AYA) cancer care in South Australia.
Advocacy
Canteen Australia wishes to thank Cancer Australia for the opportunity to contribute to the Australian Cancer Plan: 2023-2033 (Plan) consultation.
Advocacy
Medical Research Future Fund consultation to inform the third Australian Medical Research and Innovation Priorities 2020-2022.
Advocacy
Addressing the challenges of clinical trial access for Australians with rare cancers.
Advocacy
Canteen's submission advocates for a stronger focus on AYA clinical trial eligibility as a key focus for the MRFF strategy.
Advocacy
Canteen supports equity of access to clinical trials & novel therapeutics for the full spectrum of the adolescent & young adult population and therefore is supportive of the TGA proposal in the adoption of these FDA guidelines.
Advocacy
Canteen would like the orphan drug program to consider the adolescent and young adult population as a unique group with a unique biology, different to that of peadiatric or adult populations.
Advocacy
Canteen applauds the establishment of the Medical Research Future Fund (MRFF) by the Australian Government & its flexibility to provide the opportunity to shape investment that will deliver improved health.
Advocacy
Canteen made five recommendations to the committee to ensure a commitment to equitable, timely and affordable access to new cancer drugs is prioritised for adolescents and young adults.
Find out more

Contact us for more information about our policy and advocacy work.